The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
CRISPR & Cas9-Global Market Insights and Sales Trends 2024
Synopsis
CRISPR is a family of DNA sequences found within the genomes of prokaryotic organisms such as bacteria and archaea. These sequences are derived from DNA fragments from viruses that have previously infected the prokaryote and are used to detect and destroy DNA from similar viruses during subsequent infections. Hence these sequences play a key role in the antiviral defense system of prokaryotes. Cas9 is an enzyme that uses CRISPR sequences as a guide to recognize and cleave specific strands of DNA that are complementary to the CRISPR sequence. Cas9 enzymes together with CRISPR sequences form the basis of a technology known as CRISPR/Cas9 that can be used to edit genes within organisms. This type of gene editing process has a wide variety of applications including use as a basic biology research tool, development of biotechnology products, and potentially to treat diseases.
The global CRISPR & Cas9 market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of CRISPR & Cas9 in various end use industries. The expanding demands from the Biotechnology Companies, Pharmaceutical Companies, Academic Institutes and Research and Development Institutes, are propelling CRISPR & Cas9 market. Genome Editing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Genetic Engineering segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for CRISPR & Cas9 market, driven by demand from China, the second largest economy with some signs of stabilising, the CRISPR & Cas9 market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for CRISPR & Cas9, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global CRISPR & Cas9 market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global CRISPR & Cas9 market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, CRISPR & Cas9 sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of CRISPR & Cas9 covered in this report include Caribou Biosciences, Integrated DNA Technologies(IDT), CRISPR Therapeutics, Merck, Mirus Bio, Editas Medicine, Takara Bio, Thermo Fisher Scientific and Horizon Discovery Group, etc.
The global CRISPR & Cas9 market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Caribou Biosciences
Integrated DNA Technologies(IDT)
CRISPR Therapeutics
Merck
Mirus Bio
Editas Medicine
Takara Bio
Thermo Fisher Scientific
Horizon Discovery Group
Intellia Therapeutics
Agilent Technologies
Cellecta
GenScript
GeneCopoeia
Synthego
Global CRISPR & Cas9 market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global CRISPR & Cas9 market, Segment by Type:
Genome Editing
Genetic Engineering
gRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering
Global CRISPR & Cas9 market, by Application
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of CRISPR & Cas9 companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
CRISPR is a family of DNA sequences found within the genomes of prokaryotic organisms such as bacteria and archaea. These sequences are derived from DNA fragments from viruses that have previously infected the prokaryote and are used to detect and destroy DNA from similar viruses during subsequent infections. Hence these sequences play a key role in the antiviral defense system of prokaryotes. Cas9 is an enzyme that uses CRISPR sequences as a guide to recognize and cleave specific strands of DNA that are complementary to the CRISPR sequence. Cas9 enzymes together with CRISPR sequences form the basis of a technology known as CRISPR/Cas9 that can be used to edit genes within organisms. This type of gene editing process has a wide variety of applications including use as a basic biology research tool, development of biotechnology products, and potentially to treat diseases.
The global CRISPR & Cas9 market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of CRISPR & Cas9 in various end use industries. The expanding demands from the Biotechnology Companies, Pharmaceutical Companies, Academic Institutes and Research and Development Institutes, are propelling CRISPR & Cas9 market. Genome Editing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Genetic Engineering segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for CRISPR & Cas9 market, driven by demand from China, the second largest economy with some signs of stabilising, the CRISPR & Cas9 market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for CRISPR & Cas9, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global CRISPR & Cas9 market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global CRISPR & Cas9 market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, CRISPR & Cas9 sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of CRISPR & Cas9 covered in this report include Caribou Biosciences, Integrated DNA Technologies(IDT), CRISPR Therapeutics, Merck, Mirus Bio, Editas Medicine, Takara Bio, Thermo Fisher Scientific and Horizon Discovery Group, etc.
The global CRISPR & Cas9 market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Caribou Biosciences
Integrated DNA Technologies(IDT)
CRISPR Therapeutics
Merck
Mirus Bio
Editas Medicine
Takara Bio
Thermo Fisher Scientific
Horizon Discovery Group
Intellia Therapeutics
Agilent Technologies
Cellecta
GenScript
GeneCopoeia
Synthego
Global CRISPR & Cas9 market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global CRISPR & Cas9 market, Segment by Type:
Genome Editing
Genetic Engineering
gRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering
Global CRISPR & Cas9 market, by Application
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of CRISPR & Cas9 companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of CRISPR & Cas9
1.1 CRISPR & Cas9 Market Overview
1.1.1 CRISPR & Cas9 Product Scope
1.1.2 CRISPR & Cas9 Market Status and Outlook
1.2 Global CRISPR & Cas9 Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global CRISPR & Cas9 Market Size by Region (2018-2029)
1.4 Global CRISPR & Cas9 Historic Market Size by Region (2018-2023)
1.5 Global CRISPR & Cas9 Market Size Forecast by Region (2024-2029)
1.6 Key Regions, CRISPR & Cas9 Market Size (2018-2029)
1.6.1 North America CRISPR & Cas9 Market Size (2018-2029)
1.6.2 Europe CRISPR & Cas9 Market Size (2018-2029)
1.6.3 Asia-Pacific CRISPR & Cas9 Market Size (2018-2029)
1.6.4 Latin America CRISPR & Cas9 Market Size (2018-2029)
1.6.5 Middle East & Africa CRISPR & Cas9 Market Size (2018-2029)
2 CRISPR & Cas9 Market by Type
2.1 Introduction
2.1.1 Genome Editing
2.1.2 Genetic Engineering
2.1.3 gRNA Database/Gene Librar
2.1.4 CRISPR Plasmid
2.1.5 Human Stem Cells
2.1.6 Genetically Modified Organisms/Crops
2.1.7 Cell Line Engineering
2.2 Global CRISPR & Cas9 Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global CRISPR & Cas9 Historic Market Size by Type (2018-2023)
2.2.2 Global CRISPR & Cas9 Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America CRISPR & Cas9 Revenue Breakdown by Type (2018-2029)
2.3.2 Europe CRISPR & Cas9 Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific CRISPR & Cas9 Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America CRISPR & Cas9 Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa CRISPR & Cas9 Revenue Breakdown by Type (2018-2029)
3 CRISPR & Cas9 Market Overview by Application
3.1 Introduction
3.1.1 Biotechnology Companies
3.1.2 Pharmaceutical Companies
3.1.3 Academic Institutes
3.1.4 Research and Development Institutes
3.2 Global CRISPR & Cas9 Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global CRISPR & Cas9 Historic Market Size by Application (2018-2023)
3.2.2 Global CRISPR & Cas9 Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America CRISPR & Cas9 Revenue Breakdown by Application (2018-2029)
3.3.2 Europe CRISPR & Cas9 Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific CRISPR & Cas9 Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America CRISPR & Cas9 Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa CRISPR & Cas9 Revenue Breakdown by Application (2018-2029)
4 CRISPR & Cas9 Competition Analysis by Players
4.1 Global CRISPR & Cas9 Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in CRISPR & Cas9 as of 2022)
4.3 Date of Key Players Enter into CRISPR & Cas9 Market
4.4 Global Top Players CRISPR & Cas9 Headquarters and Area Served
4.5 Key Players CRISPR & Cas9 Product Solution and Service
4.6 Competitive Status
4.6.1 CRISPR & Cas9 Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Caribou Biosciences
5.1.1 Caribou Biosciences Profile
5.1.2 Caribou Biosciences Main Business
5.1.3 Caribou Biosciences CRISPR & Cas9 Products, Services and Solutions
5.1.4 Caribou Biosciences CRISPR & Cas9 Revenue (US$ Million) & (2018-2023)
5.1.5 Caribou Biosciences Recent Developments
5.2 Integrated DNA Technologies(IDT)
5.2.1 Integrated DNA Technologies(IDT) Profile
5.2.2 Integrated DNA Technologies(IDT) Main Business
5.2.3 Integrated DNA Technologies(IDT) CRISPR & Cas9 Products, Services and Solutions
5.2.4 Integrated DNA Technologies(IDT) CRISPR & Cas9 Revenue (US$ Million) & (2018-2023)
5.2.5 Integrated DNA Technologies(IDT) Recent Developments
5.3 CRISPR Therapeutics
5.3.1 CRISPR Therapeutics Profile
5.3.2 CRISPR Therapeutics Main Business
5.3.3 CRISPR Therapeutics CRISPR & Cas9 Products, Services and Solutions
5.3.4 CRISPR Therapeutics CRISPR & Cas9 Revenue (US$ Million) & (2018-2023)
5.3.5 Merck Recent Developments
5.4 Merck
5.4.1 Merck Profile
5.4.2 Merck Main Business
5.4.3 Merck CRISPR & Cas9 Products, Services and Solutions
5.4.4 Merck CRISPR & Cas9 Revenue (US$ Million) & (2018-2023)
5.4.5 Merck Recent Developments
5.5 Mirus Bio
5.5.1 Mirus Bio Profile
5.5.2 Mirus Bio Main Business
5.5.3 Mirus Bio CRISPR & Cas9 Products, Services and Solutions
5.5.4 Mirus Bio CRISPR & Cas9 Revenue (US$ Million) & (2018-2023)
5.5.5 Mirus Bio Recent Developments
5.6 Editas Medicine
5.6.1 Editas Medicine Profile
5.6.2 Editas Medicine Main Business
5.6.3 Editas Medicine CRISPR & Cas9 Products, Services and Solutions
5.6.4 Editas Medicine CRISPR & Cas9 Revenue (US$ Million) & (2018-2023)
5.6.5 Editas Medicine Recent Developments
5.7 Takara Bio
5.7.1 Takara Bio Profile
5.7.2 Takara Bio Main Business
5.7.3 Takara Bio CRISPR & Cas9 Products, Services and Solutions
5.7.4 Takara Bio CRISPR & Cas9 Revenue (US$ Million) & (2018-2023)
5.7.5 Takara Bio Recent Developments
5.8 Thermo Fisher Scientific
5.8.1 Thermo Fisher Scientific Profile
5.8.2 Thermo Fisher Scientific Main Business
5.8.3 Thermo Fisher Scientific CRISPR & Cas9 Products, Services and Solutions
5.8.4 Thermo Fisher Scientific CRISPR & Cas9 Revenue (US$ Million) & (2018-2023)
5.8.5 Thermo Fisher Scientific Recent Developments
5.9 Horizon Discovery Group
5.9.1 Horizon Discovery Group Profile
5.9.2 Horizon Discovery Group Main Business
5.9.3 Horizon Discovery Group CRISPR & Cas9 Products, Services and Solutions
5.9.4 Horizon Discovery Group CRISPR & Cas9 Revenue (US$ Million) & (2018-2023)
5.9.5 Horizon Discovery Group Recent Developments
5.10 Intellia Therapeutics
5.10.1 Intellia Therapeutics Profile
5.10.2 Intellia Therapeutics Main Business
5.10.3 Intellia Therapeutics CRISPR & Cas9 Products, Services and Solutions
5.10.4 Intellia Therapeutics CRISPR & Cas9 Revenue (US$ Million) & (2018-2023)
5.10.5 Intellia Therapeutics Recent Developments
5.11 Agilent Technologies
5.11.1 Agilent Technologies Profile
5.11.2 Agilent Technologies Main Business
5.11.3 Agilent Technologies CRISPR & Cas9 Products, Services and Solutions
5.11.4 Agilent Technologies CRISPR & Cas9 Revenue (US$ Million) & (2018-2023)
5.11.5 Agilent Technologies Recent Developments
5.12 Cellecta
5.12.1 Cellecta Profile
5.12.2 Cellecta Main Business
5.12.3 Cellecta CRISPR & Cas9 Products, Services and Solutions
5.12.4 Cellecta CRISPR & Cas9 Revenue (US$ Million) & (2018-2023)
5.12.5 Cellecta Recent Developments
5.13 GenScript
5.13.1 GenScript Profile
5.13.2 GenScript Main Business
5.13.3 GenScript CRISPR & Cas9 Products, Services and Solutions
5.13.4 GenScript CRISPR & Cas9 Revenue (US$ Million) & (2018-2023)
5.13.5 GenScript Recent Developments
5.14 GeneCopoeia
5.14.1 GeneCopoeia Profile
5.14.2 GeneCopoeia Main Business
5.14.3 GeneCopoeia CRISPR & Cas9 Products, Services and Solutions
5.14.4 GeneCopoeia CRISPR & Cas9 Revenue (US$ Million) & (2018-2023)
5.14.5 GeneCopoeia Recent Developments
5.15 Synthego
5.15.1 Synthego Profile
5.15.2 Synthego Main Business
5.15.3 Synthego CRISPR & Cas9 Products, Services and Solutions
5.15.4 Synthego CRISPR & Cas9 Revenue (US$ Million) & (2018-2023)
5.15.5 Synthego Recent Developments
6 North America
6.1 North America CRISPR & Cas9 Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe CRISPR & Cas9 Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific CRISPR & Cas9 Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America CRISPR & Cas9 Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa CRISPR & Cas9 Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 CRISPR & Cas9 Market Dynamics
11.1 CRISPR & Cas9 Industry Trends
11.2 CRISPR & Cas9 Market Drivers
11.3 CRISPR & Cas9 Market Challenges
11.4 CRISPR & Cas9 Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
